Novavax claims variant-adapted vaccine is effective against multiple strains of Covid-19 – –

0
12
Novavax claims variant-adapted vaccine is effective against multiple strains of Covid-19 – –


An 18-year-old Italian girl died of a rare form of blood clot two weeks after receiving the AstraZeneca vaccine in northern Italy, and a 34-year-old woman from the same region is in a coma.
Local media reported that the initial investigation into the teenager’s death showed that she suffered from a low blood platelet count, a condition the European Medical Agency has linked to rare blood clots in association. with the AstraZeneca vaccine.

It is not known if she declared her condition before receiving the vaccine at an “open house” last month.

Giovanni Toti, the regional governor of Liguria, said last week that Aifa, the national drug regulatory body, was investigating a direct link to jabs.

Italian officials said Friday evening AstraZeneca vaccines would be banned for people under 60 and more than a million people under 60, who were awaiting their second dose, would be vaccinated with mRNA vaccines instead. such as BioNTech / Pfizer and Moderna. The head of the government’s Covid task force, Franco Locatelli, told a press conference that it was reasonable to believe that mixing the vaccines would not be detrimental, on the contrary, it could be “beneficial” in terms efficiency.

Italy’s regional governments have been promoting youth immunizations since late May in their efforts to increase total immunizations and encourage summer tourism as the academic year draws to a close.

While Aifa said in April that AstraZeneca should be “preferably” given to people aged 60 and over, many older people have avoided the vaccine and regions have used tens of thousands of doses left on people. younger.

Immunologist Antonella Viola said that “offering AstraZeneca to young people was a mistake.”

Nino Cartabellotta, of science think tank Gimbe, said Thursday that available data suggested mRNA vaccines, like Pfizer and Moderna, should be reserved for people under the age of 50 while AstraZeneca and Johnson & Johnson should go to older people.

However, regional authorities said they had received no clear indication from the national government.

In the northern regions, such as Lombardy, Veneto, Emilia-Romagna and Liguria, reservations have been open to teenagers from the age of 12 since last week.

The open houses, where thousands of young people were vaccinated without pre-booking their vaccine, drew widespread criticism from politicians and experts who warned there was a lack of data on the effects of vaccines. on adolescents. Others said vaccines should not be wasted on people in low-risk age groups.

A total of 40.5 million vaccines have been administered in Italy with 25 percent of the Italian population fully immunized.

Government figures show that 283,000 doses have been distributed to people between the ages of 12 and 19.

Health Minister Roberto Speranza said the government was waiting for advice from its advisers before making a final decision on banning AstraZeneca for certain age groups.

LEAVE A REPLY

Please enter your comment!
Please enter your name here